Fassi E, Mandruzzato M, Zamparini M, Bianchi S, Petrelli F, Baggi A, Alberti A, Grisanti S, Berruti A (2023) Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases. Cancer Treat Res 179:107176. https://doi.org/10.1016/j.lungcan.2023.107176
Todisco A, Internò V, Stucci LS, Ostuni C, Lovero D, D’Oronzo S, Mele F, Duda L, Palmirotta R, Silvestris F (2019) Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma. Int J Biol Markers 34(4):421–426. https://doi.org/10.1177/1724600819877190
Article CAS PubMed Google Scholar
Wang Q, Zhang L, Li H, Liu L, Sun X, Liu H (2023) Clinical features and prognosis of pulmonary enteric adenocarcinoma: a retrospective study in China and the SEER database. Front Oncol 13:1099117. https://doi.org/10.3389/fonc.2023.1099117
Article CAS PubMed PubMed Central Google Scholar
Teranishi S, Sugimoto C, Nagayama H, Segawa W, Miyasaka A, Hiro S, Maeda C, Tamura H, Masumoto N, Nagahara Y, Hirama N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T (2022) Combination of pembrolizumab with platinum-containing chemotherapy for pulmonary enteric adenocarcinoma. Cancer Diagn Progn 2(2):253–257. https://doi.org/10.21873/cdp.10102
Article PubMed PubMed Central Google Scholar
Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, Ten Haken RK, Yorke ED (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76(3 Suppl):S3–S9. https://doi.org/10.1016/j.ijrobp.2009.09.040
Article PubMed PubMed Central Google Scholar
Martorana E, Castorina P, Ferini G, Forte S, Mare M (2023) Forecasting individual patients’ best time for surgery in colon-rectal cancer by tumor regression during and after neoadjuvant radiochemotherapy. J Pers Med 13(5):851. https://doi.org/10.3390/jpm13050851
Article PubMed PubMed Central Google Scholar
Lin W, Li C, Clement EA, Brown CJ, Raval MJ, Karimuddin AA, Ghuman A, Phang PT (2024) Surgical outcomes in total neoadjuvant therapy for rectal cancer versus standard long-course chemoradiation: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 279(4):620–630. https://doi.org/10.1097/SLA.0000000000006161
Tu LF, Sheng LY, Zhou JY, Wang XF, Wang YH, Shen Q, Shen YH (2021) Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: report of six cases. World J Clin Cases 9(30):9236–9243. https://doi.org/10.12998/wjcc.v9.i30.9236
Article PubMed PubMed Central Google Scholar
Remon J, Soria JC, Peters S (2021) Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol 32(12):1637–1642. https://doi.org/10.1016/j.annonc.2021.08.1994 (ESMO Guidelines Committee)
Article CAS PubMed Google Scholar
Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF 3rd, Green MR (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323(14):940–945. https://doi.org/10.1056/NEJM199010043231403
Article CAS PubMed Google Scholar
Marcenaro M, Vagge S, Belgioia L, Agnese D, Lamanna G, Mantero E, Gusinu M, Garelli S, Cavagnetto F, Agostinelli S, Corvò R (2013) Ablative or palliative stereotactic body radiotherapy with helical tomotherapy for primary or metastatic lung tumor. Anticancer Res 33(2):655–660
Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A (2018) Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 45(4):210–219. https://doi.org/10.1053/j.seminoncol.2018.06.002
Ferini G, Parisi S, Lillo S, Viola A, Minutoli F, Critelli P, Valenti V, Illari SI, Brogna A, Umana GE, Ferrantelli G, Giudice LG, Carrubba C, Zagardo V, Santacaterina A, Leotta S, Cacciola A, Pontoriero A, Pergolizzi S (2022) Impressive results after “metabolism-guided” lattice irradiation in patients submitted to palliative radiation therapy: preliminary results of LATTICE_01 multicenter study. Cancers 14(16):3909. https://doi.org/10.3390/cancers14163909
Article PubMed PubMed Central Google Scholar
Tubin S, Khan MK, Salerno G, Mourad WF, Yan W, Jeremic B (2019) Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor Hypoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment. Radiat Oncol 14(1):212. https://doi.org/10.1186/s13014-019-1410-1
Article PubMed PubMed Central Google Scholar
Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, Kalemkerian GP (2017) Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer: a phase 2 clinical trial. JAMA Oncol 3(10):1358–1365. https://doi.org/10.1001/jamaoncol.2017.0982
Article PubMed PubMed Central Google Scholar
Parisi S, Ferini G, Lillo S, Brogna A, Chillari F, Ferrantelli G, Settineri N, Santacaterina A, Platania A, Leotta S, Casablanca G, Russo A, Pontoriero A, Adamo V, Minutoli F, Bottari A, Cacciola A, Pergolizzi S (2023) Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study. Radiol Med 128(7):877–885. https://doi.org/10.1007/s11547-023-01659-w
Vadalà RE, Santacaterina A, Sindoni A, Platania A, Arcudi A, Ferini G, Mazzei MM, Marletta D, Rifatto C, Risoleti EV, Severo C, Pontoriero A, Iatì G, Pergolizzi S (2016) Stereotactic body radiotherapy in non-operable lung cancer patients. Clin Transl Oncol 18(11):1158–1159. https://doi.org/10.1007/s12094-016-1552-7
Puglisi C, Giuffrida R, Borzì G, Illari S, Caronia FP, Di Mattia P, Colarossi C, Ferini G, Martorana E, Sette G, Eramo A, Lorico A, Di Grazia A, Forte S (2022) Ex vivo irradiation of lung cancer stem cells identifies the lowest therapeutic dose needed for tumor growth arrest and mass reduction in vivo. Front Oncol 12:837400. https://doi.org/10.3389/fonc.2022.837400
Article CAS PubMed PubMed Central Google Scholar
El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L (2014) Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. https://doi.org/10.14694/EdBook_AM.2014.34.e461
Nemoto Y, Kuroda K, Oyama R, Mori M, Shimajiri S, Tanaka F (2024) Case report: pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy. Front Oncol 14:1290757. https://doi.org/10.3389/fonc.2024.1290757
Comments (0)